Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push

FierceBiotechNovartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial

AgilentAgilent Technologies, Inc. $A Shares Sold by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat

WatersWaters introduces biphenyl LC columns with low UV bleed and wide pH stability for improved aromatic separations - Chromatography Today

Lonza NewsSimulations Plus partners with Lonza and FDA on drug formulation research - Investing.com India

Lonza NewsAcetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.com

IlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina

Thermo FisherThermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory

10x Genomics Blog10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0

Lonza NewsSimulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia

IlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina

FierceBiotechAACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises

FierceBiotechRacing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset